An analysis of CD44 isoforms in 254 tumour samples obtained from The Cancer Genome Atlas RNAseqV2 demonstrated that patients with a high expression of the CD44v8-10 isoform have longer survival [173]. The gene discussed is CD44; the disease is neoplasm.